ID   KCC-TCM903
AC   CVCL_7968
SY   KCC TCM903
DR   Cosmic; 1136967
DR   Cosmic; 1556196
DR   Wikidata; Q54899637
RX   PubMed=18097577;
RX   PubMed=21362583;
RX   PubMed=21631644;
CC   Population: Japanese.
CC   Doubling time: 21.39 hours (PubMed=21362583).
CC   HLA typing: A*11:01 (Direct_author_submission).
CC   Miscellaneous: HLA typing and STR profile from personal communication of Sano, Daisuke.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,11
ST   D16S539: 9,10
ST   D18S51: 19
ST   D21S11: 29
ST   D3S1358: 17
ST   D5S818: 10
ST   D7S820: 8,11
ST   D8S1179: 14,16
ST   FGA: 20,24
ST   Penta D: 10,12
ST   Penta E: 10,21
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7965 ! KCC-T873
OI   CVCL_7967 ! KCC-TCM902
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 15
//
RX   PubMed=18097577; DOI=10.3892/or.19.1.65;
RA   Taguchi, Takahide
RA   Tsukuda, Mamoru
RA   Imagawa-Ishiguro, Yukari
RA   Kato, Yasumasa
RA   Sano, Daisuke
RT   "Involvement of EGFR in the response of squamous cell carcinoma of the
RT   head and neck cell lines to gefitinib.";
RL   Oncol. Rep. 19:65-71(2008).
//
RX   PubMed=21362583; DOI=10.1016/j.anl.2011.01.018;
RA   Sakakibara, Atsuko
RA   Tsukuda, Mamoru
RA   Kondo, Norio
RA   Ishiguro, Yukari
RA   Kimura, Machiko
RA   Fujita, Kyoko
RA   Takahashi, Hideaki
RA   Matsuda, Hideki
RT   "Examination of the optimal condition on the in vitro sensitivity to
RT   telomelysin in head and neck cancer cell lines.";
RL   Auris Nasus Larynx 38:589-599(2011).
//
RX   PubMed=21631644; DOI=10.1111/j.1349-7006.2011.01999.x;
RA   Kondo, Norio
RA   Tsukuda, Mamoru
RA   Taguchi, Takahide
RA   Nakazaki, Kouichi
RA   Sakakibara, Atsuko
RA   Takahashi, Hideaki
RA   Toth, Gabor
RA   Nishimura, Goshi
RT   "Gene status of head and neck squamous cell carcinoma cell lines and
RT   cetuximab-mediated biological activities.";
RL   Cancer Sci. 102:1717-1723(2011).
//